conclusion of clinical depression essay

Primary Care Online Resources and Education

Conclusion depression.

Depression is one of the most common conditions in primary care, but is often unrecognized, undiagnosed, and untreated. Depression has a high rate of morbidity and mortality when left untreated. Most patients suffering from depression do not complain of feeling depressed, but rather anhedonia or vague unexplained symptoms. All physicians should remain alert to effectively screen for depression in their patients. There are several screening tools for depression that are effective and feasible in primary care settings. An appropriate history, physical, initial basic lab evaluation, and mental status examination can assist the physician in diagnosing the patient with the correct depressive spectrum disorder (including bipolar disorder). Primary care physicians should carefully assess depressed patients for suicide. Depression in the elderly is not part of the normal aging process. Patients who are elderly when they have their first episode of depression have a relatively higher likelihood of developing chronic and recurring depression. The prognosis for recovery is equal in young and old patients, although remission may take longer to achieve in older patients. Elderly patients usually start antidepressants at lower doses than their younger counterparts.

Most primary care physician can successfully treat uncomplicated mild or moderate forms of major depression in their settings with careful psychiatric management (e.g., close monitoring of symptoms, side effects, etc.); maintaining a therapeutic alliance with their patient; pharmacotherapy (acute, continuation, and maintenance phases); and / or referral for psychotherapy. The following situations require referral to psychiatrist: suicide risk, bipolar disorder or a manic episode, psychotic symptoms, severe decrease in level of functioning, recurrent depression and chronic depression, depression that is refractory to treatment, cardiac disease that requires tricyclic antidepressants treatment, need for electroconvulsive therapy (ECT), lack of available support system, and any diagnostic or treatment questions.

Antidepressant medications’ effectiveness is generally comparable across classes and within classes of medications.  The medications differ in side effect profiles, drug-drug interactions, and cost.  The history of a positive response to a particular drug for an individual or a family member, as well as patient preferences, should also be taken into account.  Most psychiatrists agree that an SSRI should be the first line choice.  The dual action reuptake inhibitors venlafaxine and bupropion are generally regarded as second line agents.  Tricyclics and other mixed or dual action inhibitors are third line, and MAOI’s (monoamine oxidase inhibitors) are usually medications of last resort for patients who have not responded to other medications, due to their low tolerability, dietary restrictions, and drug-drug interactions.  Most primary care physicians would prefer that a psychiatrist manage patients requiring MAOI’s.

Psychotherapy may be a first line therapy choice for mild depression particularly when associated with psychosocial stress, interpersonal problems, or with concurrent developmental or personality disorders. Psychotherapy in mild to moderate depression is most effective in the acute phase, and in preventing relapse during continuation phase treatment. Psychotherapy is not appropriate alone for severe depression, psychosis, and bipolar disorders. For more severe depression, psychotherapy may be appropriate in combination with the use of medications. The most effective forms of psychotherapy are those with structured and brief approaches such as cognitive behavioral therapy, interpersonal therapy, and certain problem solving therapies. Regardless of the psychotherapy initiated, “psychiatric management” must be integrated at the same time.

Patients, who live with depression, and their family and friends, have enormous challenges to overcome. Primary care physicians can provide compassionate care, important education, psychiatric monitoring, social support, reassurance, and advocacy for these patients and their loved ones.

This website uses cookies to identify users, improve the user experience and requires cookies to work. By continuing to use this website, you consent to Columbia University's use of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice .

Home — Essay Samples — Nursing & Health — Psychiatry & Mental Health — Depression

Essays About Depression

Depression essay topic examples.

Explore topics like the impact of stigma on depression, compare it across age groups or in literature and media, describe the emotional journey of depression, discuss how education can help, and share personal stories related to it. These essay ideas offer a broad perspective on depression, making it easier to understand and engage with this important subject.

Argumentative Essays

Argumentative essays require you to analyze and present arguments related to depression. Here are some topic examples:

• 1. Argue whether mental health stigma contributes to the prevalence of depression in society.
• 2. Analyze the effectiveness of different treatment approaches for depression, such as therapy versus medication.

Example Introduction Paragraph for an Argumentative Essay: Depression is a pervasive mental health issue that affects millions of individuals worldwide. This essay delves into the complex relationship between mental health stigma and the prevalence of depression in society, examining the barriers to seeking help and the consequences of this stigma.

Example Conclusion Paragraph for an Argumentative Essay: In conclusion, the analysis of mental health stigma's impact on depression underscores the urgent need to challenge and dismantle the stereotypes surrounding mental health. As we reflect on the far-reaching consequences of stigma, we are called to create a society that fosters empathy, understanding, and open dialogue about mental health.

Compare and Contrast Essays

Compare and contrast essays enable you to examine similarities and differences within the context of depression. Consider these topics:

• 1. Compare and contrast the symptoms and risk factors of depression in adolescents and adults.
• 2. Analyze the similarities and differences between the portrayal of depression in literature and its depiction in modern media.

Example Introduction Paragraph for a Compare and Contrast Essay: Depression manifests differently in various age groups and mediums of expression. This essay embarks on a journey to compare and contrast the symptoms and risk factors of depression in adolescents and adults, shedding light on the unique challenges faced by each demographic.

Example Conclusion Paragraph for a Compare and Contrast Essay: In conclusion, the comparison and contrast of depression in adolescents and adults highlight the importance of tailored interventions and support systems. As we contemplate the distinct challenges faced by these age groups, we are reminded of the need for age-appropriate mental health resources and strategies.

Descriptive Essays

Descriptive essays allow you to vividly depict aspects of depression, whether it's the experience of the individual or the societal impact. Here are some topic ideas:

• 1. Describe the emotional rollercoaster of living with depression, highlighting the highs and lows of the experience.
• 2. Paint a detailed portrait of the consequences of untreated depression on an individual's personal and professional life.

Example Introduction Paragraph for a Descriptive Essay: Depression is a complex emotional journey that defies easy characterization. This essay embarks on a descriptive exploration of the emotional rollercoaster that individuals with depression experience, delving into the profound impact it has on their daily lives.

Example Conclusion Paragraph for a Descriptive Essay: In conclusion, the descriptive portrayal of the emotional rollercoaster of depression underscores the need for empathy and support for those grappling with this condition. Through this exploration, we are reminded of the resilience of the human spirit and the importance of compassionate understanding.

Persuasive Essays

Persuasive essays involve arguing a point of view related to depression. Consider these persuasive topics:

• 1. Persuade your readers that incorporating mental health education into the school curriculum can reduce the prevalence of depression among students.
• 2. Argue for or against the idea that employers should prioritize the mental well-being of their employees to combat workplace depression.

Example Introduction Paragraph for a Persuasive Essay: The prevalence of depression underscores the urgent need for proactive measures to address mental health. This persuasive essay asserts that integrating mental health education into the school curriculum can significantly reduce the prevalence of depression among students, offering them the tools to navigate emotional challenges.

Example Conclusion Paragraph for a Persuasive Essay: In conclusion, the persuasive argument for mental health education in schools highlights the potential for early intervention and prevention. As we consider the well-being of future generations, we are called to prioritize mental health education as an essential component of a holistic education system.

Narrative Essays

Narrative essays offer you the opportunity to tell a story or share personal experiences related to depression. Explore these narrative essay topics:

• 1. Narrate a personal experience of overcoming depression or supporting a loved one through their journey.
• 2. Imagine yourself in a fictional scenario where you advocate for mental health awareness and destigmatization on a global scale.

Example Introduction Paragraph for a Narrative Essay: Personal experiences with depression can be transformative and enlightening. This narrative essay delves into a personal journey of overcoming depression, highlighting the challenges faced, the support received, and the lessons learned along the way.

Example Conclusion Paragraph for a Narrative Essay: In conclusion, the narrative of my personal journey through depression reminds us of the resilience of the human spirit and the power of compassion and understanding. As we reflect on our own experiences, we are encouraged to share our stories and contribute to the ongoing conversation about mental health.

A Narrative About Depression: Navigating The Abyss

Depression: understanding the silent epidemic, made-to-order essay as fast as you need it.

Each essay is customized to cater to your unique preferences

+ experts online

Depression: an Informative Exploration

The epidemic of depression among students and teenagers, the effects of depression in your body and its treatment, the issue of depression and its reality nowadays, let us write you an essay from scratch.

• 450+ experts on 30 subjects ready to help
• Custom essay delivered in as few as 3 hours

Overview of Biological Predispositions and Risk Factors Associated with Depression

How to overcome depression and anxiety, depression: definition, risks, symptoms and treatment, the best way to help someone who is depressed, get a personalized essay in under 3 hours.

Expert-written essays crafted with your exact needs in mind

The Issue of Depression: Mental Battle

What is a depression, living in depression: a firsthand account, teen depression - symptoms and causes, adolescent depression and its contribution to teenage suicides, the issue of depression and its affect in an emerging adulthood, depression: definition and ways of resolving caused problems, depression in teenagers: causes and ways to overcome, depression and its main causes, genetic disorder report: clinical depression, the way teachers can help their students to overcome anxiety and depression, depression and its effects of mind and body, the effectiveness of cognitive behavioural therapy (cbt) for treating individuals with depression and anxiety, how to overcome teenage depression, depression as the reason of serious health problems and suicide, a depressing world with different obstacles, the link between self-esteem and adolescent depression, darwinian psychology and depression: the gender differential hypothesis, prevention of depression, anxiety and burnout in resident doctors – a systematic review, dysregulated processing of negative and positive responses in depression.

Depression, known as major depressive disorder or clinical depression, is a psychological condition characterized by enduring feelings of sadness and a significant loss of interest in activities. It is a mood disorder that affects a person's emotional state, thoughts, behaviors, and overall well-being.

Its origin can be traced back to ancient civilizations, where melancholia was described as a state of sadness and melancholy. In the 19th century, depression began to be studied more systematically, and terms such as "melancholic depression" and "nervous breakdown" emerged. The understanding and classification of depression have evolved over time. In the early 20th century, Sigmund Freud and other psychoanalysts explored the role of unconscious conflicts in the development of depression. In the mid-20th century, the Diagnostic and Statistical Manual of Mental Disorders (DSM) was established, providing a standardized criteria for diagnosing depressive disorders.

Biological Factors: Genetic predisposition plays a role in depression, as individuals with a family history of the disorder are at a higher risk. Psychological Factors: These may include a history of trauma or abuse, low self-esteem, pessimistic thinking patterns, and a tendency to ruminate on negative thoughts. Environmental Factors: Adverse life events, such as the loss of a loved one, financial difficulties, relationship problems, or chronic stress, can increase the risk of depression. Additionally, living in a socioeconomically disadvantaged area or lacking access to social support can be contributing factors. Health-related Factors: Chronic illnesses, such as cardiovascular disease, diabetes, and chronic pain, are associated with a higher risk of depression. Substance abuse and certain medications can also increase vulnerability to depression. Developmental Factors: Certain life stages, including adolescence and the postpartum period, bring about unique challenges and changes that can contribute to the development of depression.

Depression is characterized by a range of symptoms that affect an individual's emotional, cognitive, and physical well-being. These characteristics can vary in intensity and duration but generally include persistent feelings of sadness, hopelessness, and a loss of interest or pleasure in activities once enjoyed. One prominent characteristic of depression is a noticeable change in mood, which can manifest as a constant feeling of sadness or emptiness. Individuals may also experience a significant decrease or increase in appetite, leading to weight loss or gain. Sleep disturbances, such as insomnia or excessive sleepiness, are common as well. Depression can impact cognitive functioning, causing difficulties in concentration, decision-making, and memory recall. Negative thoughts, self-criticism, and feelings of guilt or worthlessness are also common cognitive symptoms. Furthermore, physical symptoms may arise, including fatigue, low energy levels, and a general lack of motivation. Physical aches and pains, without an apparent medical cause, may also be present.

The treatment of depression typically involves a comprehensive approach that addresses both the physical and psychological aspects of the condition. It is important to note that the most effective treatment may vary for each individual, and a personalized approach is often necessary. One common form of treatment is psychotherapy, which involves talking to a mental health professional to explore and address the underlying causes and triggers of depression. Cognitive-behavioral therapy (CBT) is a widely used approach that helps individuals identify and change negative thought patterns and behaviors associated with depression. In some cases, medication may be prescribed to help manage depressive symptoms. Antidepressant medications work by balancing neurotransmitters in the brain that are associated with mood regulation. It is crucial to work closely with a healthcare provider to find the right medication and dosage that suits an individual's needs. Additionally, lifestyle changes can play a significant role in managing depression. Regular exercise, a balanced diet, sufficient sleep, and stress reduction techniques can all contribute to improving mood and overall well-being. In severe cases of depression, when other treatments have not been effective, electroconvulsive therapy (ECT) may be considered. ECT involves administering controlled electric currents to the brain to induce a brief seizure, which can have a positive impact on depressive symptoms.

1. According to the World Health Organization (WHO), over 264 million people worldwide suffer from depression, making it one of the leading causes of disability globally. 2. Depression can affect people of all ages, including children and adolescents. In fact, the prevalence of depression in young people is increasing, with an estimated 3.3 million adolescents in the United States experiencing at least one major depressive episode in a year. 3. Research has shown that there is a strong link between depression and other physical health conditions. People with depression are more likely to experience chronic pain, cardiovascular diseases, and autoimmune disorders, among other medical conditions.

The topic of depression holds immense significance and should be explored through essays due to its widespread impact on individuals and society as a whole. Understanding and raising awareness about depression is crucial for several reasons. Firstly, depression affects a significant portion of the global population, making it a pressing public health issue. Exploring its causes, symptoms, and treatment options can contribute to better mental health outcomes and improved quality of life for individuals affected by this condition. Additionally, writing an essay about depression can help combat the stigma surrounding mental health. By promoting open discussions and providing accurate information, essays can challenge misconceptions and foster empathy and support for those experiencing depression. Furthermore, studying depression allows for a deeper examination of its complex nature, including its psychological, biological, and sociocultural factors. Lastly, essays on depression can highlight the importance of early detection and intervention, promoting timely help-seeking behaviors and reducing the burden of the condition on individuals and healthcare systems. By shedding light on this critical topic, essays have the potential to educate, inspire action, and contribute to the overall well-being of individuals and society.

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. 2. World Health Organization. (2017). Depression and other common mental disorders: Global health estimates. World Health Organization. 3. Kessler, R. C., Bromet, E. J., & Quinlan, J. (2013). The burden of mental disorders: Global perspectives from the WHO World Mental Health Surveys. Cambridge University Press. 4. Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. Guilford Press. 5. Nierenberg, A. A., & DeCecco, L. M. (2001). Definitions and diagnosis of depression. The Journal of Clinical Psychiatry, 62(Suppl 22), 5-9. 6. Greenberg, P. E., Fournier, A. A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). Journal of Clinical Psychiatry, 76(2), 155-162. 7. Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013). A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry, 58(7), 376-385. 8. Hirschfeld, R. M. A. (2014). The comorbidity of major depression and anxiety disorders: Recognition and management in primary care. Primary Care Companion for CNS Disorders, 16(2), PCC.13r01611. 9. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., ... & Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905-1917. 10. Kendler, K. S., Kessler, R. C., Walters, E. E., MacLean, C., Neale, M. C., Heath, A. C., & Eaves, L. J. (1995). Stressful life events, genetic liability, and onset of an episode of major depression in women. American Journal of Psychiatry, 152(6), 833-842.

Relevant topics

• Mental Health
• Eating Disorders
• Drug Addiction

By clicking “Check Writers’ Offers”, you agree to our terms of service and privacy policy . We’ll occasionally send you promo and account related email

No need to pay just yet!

We use cookies to personalyze your web-site experience. By continuing we’ll assume you board with our cookie policy .

• Instructions Followed To The Letter
• Deadlines Met At Every Stage
• Unique And Plagiarism Free

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• J Gen Intern Med
• v.14(9); 1999 Sep

Awareness, Diagnosis, and Treatment of Depression

Larry s goldman.

1 Council on Scientific Affairs, American Medical Association Council on Scientific Affairs, American Medical Association, Chicago, Ill

Nancy H Nielsen

Hunter c champion.

To review recent findings on the epidemiology, burden, diagnosis, comorbidity, and treatment of depression, particularly in general medical settings; to delineate barriers to the recognition, diagnosis, and optimal management of depression in general medical settings; and to summarize efforts under way to reduce some of these barriers.

M edline searches were conducted to identify scientific articles published during the previous 10 years addressing depression in general medical settings and epidemiology, co-occurring conditions, diagnosis, costs, outcomes, and treatment. Articles relevant to the objective were selected and summarized.

CONCLUSIONS

Depression occurs commonly, causing suffering, functional impairment, increased risk of suicide, added health care costs, and productivity losses. Effective treatments are available both when depression occurs alone and when it co-occurs with general medical illnesses. Many cases of depression seen in general medical settings are suitable for treatment within those settings. About half of all cases of depression in primary care settings are recognized, although subsequent treatments often fall short of existing practice guidelines. When treatments of documented efficacy are used, short-term patient outcomes are generally good. Barriers to diagnosing and treating depression include stigma; patient somatization and denial; physician knowledge and skill deficits; limited time; lack of availability of providers and treatments; limitations of third-party coverage; and restrictions on specialist, drug, and psychotherapeutic care. Public and professional education efforts, destigmatization, and improvement in access to mental health care are all needed to reduce these barriers.

This report reviews recent findings on the epidemiology, burden, diagnosis, comorbidity, and treatment of depression, particularly in general medical settings; describes barriers to the recognition, diagnosis, and optimal management of depression in general medical settings; and summarizes efforts under way to reduce these barriers. The American Medical Association's Council on Scientific Affairs produced a series of reports on depression in 1991. 1

Major depression is the depressive disorder on which most research has been conducted. Other depressive disorders, such as dysthmyic disorder (“chronic” depression) and mixed depressive-anxiety states, are also common in general medical settings but have been studied far less. Similarly, most research has been done in adult populations; this report notes a few instances of information about children. Except for comoribidity, most of the research in this area has been in primary care settings rather than in more specialized medical environments; most research on treatment has been conducted in specialty mental health settings.

EPIDEMIOLOGY IN GENERAL MEDICAL SETTINGS

Depressive disorders are common in the general population, with a point prevalence of about 2% to 4% for major depressions 2 and about a 20% lifetime risk for the development of major depression or dysthymic disorder. 3 , 4 The rate of depression among women is 2 to 3 times that of men. 5 These findings are based on large community surveys using structured interviews. Of those seeking help for depression in the United States, nearly three fourths go to a primary care physician rather than to a mental health professional. The most common presentation in primary care is not dysphoria but rather complaints of sleep disturbance, fatigue, or pain. 6 Overall, 5% to 10% of ambulatory primary care patients and 10% to 14% of medical inpatients suffer from major depression. 7 One study in a general internal medicine practice treating a diverse population found that 10% of the patients had diagnosable depressive disorders, while 11% had a disorder with depressive symptoms that did not fit into any standard diagnostic categories 8 ; this underscores the high prevalence of depressive complaints that do not fit into current diagnostic schemes.

Another study examined more than 1,000 primary care patients whose diagnostic screen was positive for major depression and who then underwent a psychiatric evaluation. 9 Seventy percent of these patients were suffering from major depression that could be treated in a primary care setting, 13% had major depression but required specialty sector care, and 17% had conditions other than major depression. Of those with major depression suitable for primary care treatment, nearly 75% had suffered at some time during their life from an additional Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) axis I disorder (most commonly generalized anxiety or panic disorder), 10 and 68% were felt to have an axis II (personality) disorder. A high percentage had experienced episodes of major depression prior to the study episode. This study illustrates both benefits and limitations of screening, the predominance of cases suitable for primary care setting treatment, the need to inquire about past history of depression, and the high rates at which other psychiatric disorders co-occur with depression.

Among the well-known burdens caused by depression are patient suffering, family distress and conflict, impaired cognitive development of young children in cases of postpartum depression, 11 and the strikingly increased risk of suicide. More recent studies have examined the impact on functioning and the economic burdens. The Medical Outcomes Study looked at patient physical functioning in several chronic diseases. Patients with depression had functioning scores about the same as those with advanced coronary artery disease, scores that were in turn lower than all other conditions studied, including hypertension, diabetes mellitus, and arthritis. 12 This impairment in functioning, when coupled with the high prevalence, chronic or relapsing course, and frequent early onset, led a group of World Health Organization researchers to conclude that unipolar major depression is the leading cause of disability worldwide. 13 Functional improvement occurs with effective treatment.

Costs of depression in the United States have been estimated at $43 billion per year. 14 Only 30% of the cost is from direct medical care; the remainder is from premature death and impaired workplace productivity. The economic cost to employers is estimated at $6,000 per depressed worker per year. 15

The effects of depression on consumption of medical care are striking. When the diagnosis of depression is missed, the search for physical explanations of symptoms causes unnecessary increases in medical utilization rates. When depression co-occurs with other general medical conditions, patient adherence to treatment is worsened, chances for improvement or recovery from the other condition are lessened, and health care costs are further increased. 16 One study in a large group HMO compared two groups of “high utilizers” (i.e., patients whose annual medical expenses were above the HMO median). Costs for high utilizers who were depressed were $1,500 higher per year than for those who were not depressed. 17 Health care costs in patients with depression and co-occurring medical illness are increased even when the nature and severity of the medical condition are controlled. 18 , 19

The diagnosis of major depression is fundamentally clinical. As with most psychiatric disorders, it is made on the basis of a careful clinical interview and mental status examination. Considerable evidence suggests that such an interview is comparable in sensitivity and specificity to many radiologic and laboratory tests commonly used in medicine. The criteria in the DSM-IV ( Table 1 ) are generally considered the standard diagnostic approach. Major depression is a syndromal diagnosis: on the basis of the patient's medical history and physical examination, it may be appropriate to consider other psychiatric disorders (obsessive-compulsive disorder, panic disorder, bulimia nervosa, dementia), general medical conditions, medications, or a substance use disorder as etiologic and to pursue relevant diagnostic investigations.

Criteria for Major Depressive Episode *

A number of screening tools are available to help physicians identify patients most likely to be depressed. As with most screening instruments, they tend to be fairly sensitive but not too specific for identifying depression. Most authors suggest screening when the physician has some a priori suspicion of depression, typically a specific depressive symptom, unexplained physical symptoms, impaired functioning, or subjective distress out of proportion to a known general medical condition, or another psychiatric disorder. Physicians must interpret specific screening results correctly and appreciate the need to carry out further clinical assessment. No preventive service guide calls for depression screening in asymptomatic individuals. 20 , 21

Long-established, symptom-oriented patient self-report screens include the General Health Questionnaire, 22 the Beck Depression Inventory, 23 the Symptom Checklist, 24 the Inventory of Depressive Symptoms, 25 and the Zung Depression Scale. 26 Scores above a predetermined cutoff suggest the need to perform a more comprehensive evaluation for depression. These screens have sensitivities of 70% to 85% and specificities of about 80%. The Center for Epidemiologic Studies Depression scale 27 and the shortened Geriatric Depression Scale 28 have been proposed as particularly valuable in the elderly. 29 These tools are designed simply to produce a depression rating (severity) score; however, two more recent instruments, the Symptom-Driven Diagnostic System for Primary Care 30 and the Primary Care Evaluation of Mental Disorders, 31 are diagnosis-oriented, patient-administered screens that are supplemented by a clinician-driven diagnostic module if any of the patient screens are positive. These instruments probe for several different psychiatric disorders, including major depression. There also are other symptom checklists or inventories. All screens require diagnostic confirmation by a careful clinical interview.

The primary care version of DSM-IV provides in abbreviated form the DSM-IV diagnostic criteria of the mental disorders most commonly seen in primary care settings, including depression. 32 It also contains symptom-driven algorithms to move from a patient's complaint to a specific diagnosis. A pediatric version has been developed by the American Academy of Pediatrics. 33 The World Health Organization has developed a primary health care version of the International Classification of Diseases dealing with mental disorders (ICD-10 PHC, chapter 5) that contains cards with information about the common complaints, diagnosis, and management of 24 common psychiatric disorders. 34

Several aspects of the DSM approach may be problematic in a medical setting. A number of the symptoms are somatic. Although the diagnostic criteria give equal weighting to all nine symptoms, clinicians often fail to consider depression as part of a differential diagnosis of the patient's chief complaint unless the complaint itself is of dysphoria or the patient is observably and notably sad. Patients may tend to emphasize physical symptoms because these are most troubling, because they are reluctant to disclose emotional distress, or because they believe the physician will be most interested in or helpful for those symptoms. At times, it may be difficult to determine whether any particular symptom is caused by a depression or by another medical disorder.

COMORBIDITY

Depression occurs frequently with anxiety disorders and with substance use disorders, including alcoholism. More recent research highlights the relation between nicotine addiction and depression. 35 Diagnosis of co-occurring depression and substance abuse is complicated, as either condition may overshadow the other. A number of recent textbooks and review articles are devoted to issues of diagnosing and treating depression and other psychiatric disorders in general medical populations. 36 – 38

Recent studies and reviews confirm the high rates of depression and its morbidity seen in many general medical conditions, especially those that affect the central nervous system. Table 2 summarizes some of the studies examining the rates of depression in various medical conditions.

Rates of Depression Co-Occurring with Other Medical Conditions.

Advanced age also may be an important factor that exists concurrently with depression. Depression in the elderly may be particularly hazardous and costly if untreated, and it also may be more complicated to treat. 39 – 41 Finally, untreated depression in the presence of terminal medical illness is one of several psychosocial factors associated with patient requests for physician assistance in dying. 42

TRENDS IN TREATMENT

Recent trends in the treatment of depression have been driven by scientific advances as well as changes in the practice environment. Over the past 10 years, nine newly marketed antidepressants (fluoxetine [Prozac], sertraline [Zoloft], paroxitene [Paxil], bupropion [Wellbutrin], venlafaxine [Effexor], fluvoxamine [Lu-vox], nefazodone [Serzone], mirtazapine [Remeron], and citalopram [Celexa]) were released in the United States. These drugs are structurally and pharmacologically quite different from the older tricyclic and monoamine oxidase inhibitor agents. For the most part, these drugs exhibit a more benign side effect profile, a simplified dosing strategy, better patient adherence, and a lower risk of death in overdose situations compared with the older drugs. As a result, they have quickly been adopted in medical settings, and several are among the most commonly prescribed drugs in all of medicine. These newer drugs do, however, continue to demonstrate the delay in full therapeutic action (several or more weeks) seen with older drugs, they generally lack a clear relation between serum drug level and therapeutic response, and some pose risks of significant drug-drug interactions with other medications. 43

Parallel advances in the development and testing of psychotherapies have occurred as well. Cognitive behavioral and interpersonal psychotherapy, which are both structured and time-limited in nature, have been shown to be equal in efficacy to antidepressant medication for mild-to-moderate, nonbipolar, nonpsychotic major depression, the type seen most commonly in general medical settings. 44 Such therapies offer a genuine alternative to patients intolerant of or averse to using antidepressant medications, to those who prefer psychotherapy, and to pregnant or nursing women. It is still uncertain whether combining pharmacotherapy and psychotherapy yields better outcomes than either form of treatment alone. 45 , 46 The exact role of other forms of psychotherapy (e.g., behavioral, marital/family, group, psychodynamic) in depression also remains unclear.

These specific therapies for major depression are different from the general supportive care offered by many physicians. Although such support may be vital to the doctor-patient relationship, may encourage medication adherence, and can be helpful to the patient, there is no empirical evidence of its efficacy as a specific treatment modality. Few nonpsychiatrist physicians are trained in cognitive-behavioral or interpersonal psychotherapy, although other specific forms of counseling by the primary care physician may also improve outcomes. 47 , 48 Primary care physicians most commonly prescribe medications themselves as a sole treatment modality, offer a few sessions of supportive psychotherapy, or refer patients to mental health practitioners for psychotherapy (either as sole therapy or in conjunction with primary care antidepressant prescribing, so-called split treatments). The impact on outcomes of these different provider approaches is not well understood. 49

A further development in depression treatment is the growing appreciation of depression as a chronic, often recurrent illness. At least 50% of those who experience an episode of major depression without a co-occurrent general medical condition will go on to have another, and after several such episodes the risk of future recurrences probably exceeds 90%. In addition, while most patients make a full recovery from any particular episode (with or without treatment), about one fifth to one third have a residual persistence of symptoms or impairment in functioning or both. 50 Thus, interest has increased in using medications prophylactically (after a likely episode recovery but in anticipation of a subsequent one), particularly after the patient has experienced several episodes. In addition, studies have sought to clarify whether any specific psychotherapeutic interventions afford a protective effect against future episodes (i.e., after cessation of psychotherapy or when it is provided at infrequent intervals). 51 Much of the information on illness prevalence, course, and treatment efficacy was reviewed, synthesized, and published as a set of treatment guidelines on depression for primary care settings by the Agency for Health Care Policy and Research (AHCPR). 52

Several trends also have emerged as a result of changes in health care delivery systems. There is growing appreciation of the important role of the primary care sector in caring for those with a variety of psychiatric illnesses. 53 The “gatekeeper” role has come to include an increased pressure on primary care physicians to diagnose and treat depression themselves. This pressure is both clinical (they can provide more integrated care) and economic (to limit more costly specialty sector referrals). As with other illnesses, patients with uncomplicated depression are likely to receive care from their primary care physician, while those with complex (e.g., bipolar, psychotic, suicidal, other co-occurrent psychiatric disorders such as substance use disorders) or treatment-refractory illnesses, or those requiring specialized treatments (e.g., electroconvulsive therapy, light therapy, cognitive-behavioral psychotherapy) may be followed in the specialty mental health sector.

There has been a dramatic rise in recent years of mental or behavioral health “carve outs,” where an organizational entity contracts with a managed care organization or other general health provider to provide all services for patients identified as in need of mental health services. This entity may be clinically or geographically distinct from the primary medical care setting. The proposed advantage of this approach is to guarantee an expert set of specialized clinicians and services that can care for all of a patient's mental health problems (e.g., depression, substance abuse, personality disorders) and provide an optimal level of access and treatment setting (e.g., outpatient office, partial hospital, detoxification setting, inpatient hospital). Potential disadvantages center on the fact that such care is not integrated into the patient's general medical care. Thus, the patient may need to utilize different facilities, the record-keeping system is separate, and the feedback loop between referring and treating clinician is stretched or nonexistent. Unlike traditional practice in which the referring physician selects the consultant (often based on previous shared experiences), carved-out care seldom allows the primary care physician to decide to whom he or she is sending the patient or even which type of mental health professional the patient will see. However, to date there has been little research to inform this debate.

MANAGEMENT IN GENERAL MEDICAL SETTINGS

A number of studies indicate that about half of those with psychiatric disorders (including depression) are detected in primary care settings. 54 Only about half of these receive any treatment, and that occurs largely (50% to 75% of the time) in the primary care setting rather than in the mental health care system.

A multisite outpatient study of health care system factors in the recognition and care of depressed patients found that 46% to 51% of these patients were recognized by medical clinicians, while 78% to 87% were recognized by mental health specialists. 55 Among the medical clinicians, depression was less likely to be recognized or treated under a prepaid system than under fee-for-service care. Nonetheless, depression outcomes in the general medical sector were similar under prepaid and fee-for-service care (because rates of treatment were similarly low to moderate in both payment systems). 56

Several studies have examined physician factors that may influence recognition of depression. In one study, high physician interest in psychosocial issues did not correlate with the type of interviewing behaviors necessary to diagnose depression. Several specific interviewing behaviors did, however, lead to great recognition of depression, including open-ended questioning, periodically summarizing the patient's information, and responding to nonverbal and emotional patient cues. 57 Robbins and colleagues found that primary care physicians who were more sensitive to affective and nonverbal patient cues made more psychiatric diagnoses, and physicians who tended to blame patients for their depression made fewer and less accurate diagnoses. 58 Overall, these authors found that false-positive psychiatric diagnoses were uncommon.

A few studies have examined the impact of recognition on patient outcomes. Simon and VonKorff screened patients attending a primary care clinic and interviewed those with positive depression screens: they found that unrecognized and untreated cases had a milder self-limited illness. 59 As a result, they concluded that a focus on increased recognition might not improve overall outcomes significantly. The Groningen Primary Care Study also found that recognition of psychological disorders by primary care physicians was not associated with better patient outcomes, and concluded that recognition was necessary but not sufficient unless primary care physicians had the skills or resources to provide appropriate treatments after making a diagnosis. 60

Katon and Gonzales reviewed all randomized trials of mental health interventions in primary care settings developed by consultation-liaison psychiatrists. 61 They too concluded that screening interventions and feedback to the primary care physician somewhat increased recognition and treatment of depression, but that the effect on patient outcomes was unclear. In general, although the link between diagnosis and treatment of depression may seem conceptually clear, in practice these tasks are not invariably linked. 62

A recent review of studies of unrecognized psychiatric illnesses in general medical outpatient settings found that: (1) half of the disorders were unrecognized; (2) the natural history of unrecognized depression suggested no worsening of course; and (3) interventions to teach physicians led to greater recognition and treatment but had little short-term effect on symptoms or health care use. 63 The review concluded that efforts to increase recognition alone that are not connected to strategies to improve management may not reduce patient suffering or decrease health care costs. Nonetheless, this conclusion may be less applicable over a longer period of time, as some milder depressions may worsen slowly over time.

Four studies have examined the rates of recognition of psychiatric disorders in children in primary care settings: the percentage of cases recognized ranged from 17% to 59%. 64 – 67 Insufficient data exist to reach any conclusions about the clinical or economic significance of such nonrecognition in children.

Even when patients' depression is recognized, treatment provided is highly variable. One study on high utilizers of one HMO's primary care medical services (a patient group known to be at high risk of depression) found that half of these patients were clinically depressed, yet only 45% of the depressed high utilizers had received an antidepressant during the preceding year. 68 Only one fourth of those receiving an antidepressant received a dose or duration of treatment that would be considered adequate by relevant practice parameters.

Another study that looked at depression treatment in a variety of different primary care settings found that only 11% of mildly and 29% of markedly depressed patients received any antidepressant. 69 In that same study, only about one third of all of the patients cared for by psychiatrists received any antidepressant, and only 41% received an adequate dose. In another study in a group of academically affiliated primary care offices, physicians were explicitly informed by investigators of patients with major depression and urged to provide treatment. 70 Only about three fourths of the patients were treated, 60% of them with antidepressants; only 43% of those prescribed antidepressants received them in amounts consistent with AHCPR guidelines.

Psychotherapy or counseling is even scarcer in primary care settings. In the Medical Outcomes Study conducted at multiple sites, less than half of depressed patients in the general medical sector settings received 3 minutes or more of counseling from their primary care physicians. 71 Counseling rates were lower under prepaid than fee-for-service plans.

A limited number of studies have examined the effect of increasing treatment to depressed patients by various methods. One small uncontrolled study examined high utilizers who were depressed and who were treated by the primary care physician with antidepressants following a study protocol. There were significant reductions in symptoms, improvements in quality-of-life measures, and increases in work performance. Overall general medical costs fell by 50%, and even when depression treatment costs were figured in, there remained a modest cost saving. 72

Sturm and Wells estimated the effects of restricting access to specialty care and predicted that shifting patients away from mental health specialists decreased costs but worsened patients' functional outcomes. 73 They suggested that there should be quality improvement in the general medical sector rather than changing the primary care–specialty care mix. Schulberg and colleagues attempted to have primary care physicians follow AHCPR guidelines for treatment of depression. 74 They found that doing so is feasible but challenging, that keeping patients in treatment is problematic (only 33% completed a full treatment regimen per the guidelines), and that physicians need to be more flexible than the guide regimens suggest. 75 There was a 70% recovery at 8 months when AHCPR guidelines were adhered to versus a 20% recovery among patients receiving usual care, suggesting high effectiveness of the guidelines. In those recovering, functional improvements occurred across a broad range of domains in addition to symptomatic improvement. 76

Two recent studies looked at a multifaceted intervention that integrated a psychiatrist or psychologist into the primary care area. The intervention consisted of a structured program of patient education, behavioral counseling, improved psychopharmacologic management, drug refill tracking, and physician education. This approach led to significant improvement in depression, patient satisfaction, medication adherence, and cost-effectiveness when compared with usual care, but only for those with major depression and not for those with minor (milder) depression. 77 – 79

BARRIERS TO OPTIMAL MANAGEMENT

Recognition barriers.

Because of the stigma still attached to psychiatric illnesses, many patients are reluctant to acknowledge to themselves or their physicians that they are experiencing emotional distress. Patients may deny or minimize symptoms, rationalize them as expectable because of life stresses or as due to other general medical problems, believe them to be failures of will or moral shortcomings, or not see them as within the physician's purview or capabilities. These attitudes may be reinforced by familial or cultural beliefs. Similarly, patients may be reluctant to disclose information they fear could be included in insurance or employment records; they may be especially concerned about having a psychiatric diagnosis recorded. 80

Attention also has been called to physician deficits in this area. 81 , 82 Some physicians harbor the belief that depression is not a “real” illness. Some believe that depression reflects a personal shortcoming or laziness and is thus something the patient could improve with more effort, willpower, or “positive thinking.” Others are doubtful about the existence of depression as a clinical entity because of the absence of confirmatory laboratory or radiologic studies. These doubts may take different forms, from simply never inquiring about depressive symptoms to having an unduly high threshold for considering depression in the differential diagnosis of a patient's chief complaint.

Even when attitudes are appropriate, some physicians lack the requisite skills to properly elicit the relevant history. 83 Many adopt a highly focused closed-ended interviewing technique that may prevent patients from bringing up affectively laden or psychosocial material. Failure to recognize nonverbal cues and to ask follow-up questions in response to indications of distress are also potential impediments to obtaining an appropriate history. Some physicians fail to offer empathic, supportive comments during the interview, cues that patients may interpret as lack of interest or unwillingness to discuss these concerns. Finally, some physicians, uncomfortable with displays of affect, may consciously or unwittingly steer the interview toward less difficult areas.

Differences in age, gender, or cultural background may result in barriers in the interaction between patient and physician. One of the most common interactional barriers is the medicalization of presenting complaints. 84 As discussed above, 50% to 70% of depressed patients will present with somatic rather than psychological complaints. 85 Patients may believe or hope that something physical is wrong, the cause will be found, and they will be healed. Because of stigma issues, there may be a potent investment on the part of the patient in keeping the focus on the somatic complaints. The physician, too, may feel more comfortable in the physical realm, and the assessment will emphasize these complaints. This focus in medical training, which covertly reinforces a more limited biomedical rather than biopsychosocial model, has been referred to as the “hidden medical curriculum.” 86 Symptoms that are not physical in nature (e.g., sadness, guilt, hopelessness) may not be asked about or voiced by the patient, and the recognition that the patient has a psychiatric disorder eludes both patient and physician. This appears to be especially the case among older patients.

Medicalization and other barriers may be compounded by the increasing time demands of an office visit. Physicians may be reluctant to elicit affectively laden information that can require more time to explore and to reach closure. Patients also may be reluctant to discuss topics for which they know insufficient time may be available. In addition, physicians often have a multiplicity of tasks during an office visit, such as assessment and ongoing management of known general medical problems, prevention and health maintenance, and paperwork. Limited remuneration for the time spent on assessing depression may influence the outcome.

In addition, the lack of appropriate performance standards for depression in managed care and other medical settings limits knowledge of actual practice and impedes feedback to clinicians, administrators, consumers, and purchasers of health care.

Diagnostic Barriers

One group of barriers concerns physician appraisal of the patient's willingness to consider having a psychiatric disorder. Physicians may not wish to compromise patient confidentiality or may fear offending patients or families by making a psychiatric diagnosis. At times, physicians may accurately assess that a patient is simply not ready to accept a diagnosis (e.g., by observing defensiveness during relevant inquiries), so they defer a full assessment decision about the diagnosis.

Other barriers pertain to appropriate diagnostic criteria. The DSM-IV criteria were developed largely in psychiatric settings, and some have questioned their applicability to primary care and other medical situations. One controversy concerns patients who meet some but not all criteria for major depression, a group encountered far more often in primary care than psychiatric settings. Another problematic group are those with mixed symptoms of depression and anxiety that fall short of DSM-IV thresholds for a disorder. Patients in either of these groups may be symptomatic and have functional impairment but, because they fail to meet full diagnostic criteria, may not be appropriately diagnosed or treated.

A third set of factors relates to inadequate physician knowledge about depression. Physicians may be unfamiliar with the diagnostic criteria and thus may not appreciate the differences between transient sadness, bereavement, and a clinical illness. Others understand the diagnostic criteria but fail to appreciate the import of the illness: they may believe it will remit spontaneously, that it is understandable in the context of the patient's life, or that it does not cause much suffering or dysfunction. Thus, they may not perform a careful diagnostic assessment because they would not be inclined to treat anyway.

The complexities of some clinical situations also may impede an accurate diagnosis. Symptoms of certain concurrent general medical conditions may overlap those of depression and may be attributed to the concurrent condition. A similar attribution problem may occur when a patient is taking medications that can cause depressive symptoms. When patients have another psychiatric disorder in addition to depression (e.g., panic disorder), that condition's symptoms might overshadow the depression and cause a missed diagnosis. Finally, depression may simulate other psychiatric disorders (e.g., dementia) and thus confound the diagnostic process. One study found that recognition of depression by primary care physicians was only 29% in patients with comorbid general medical illness versus 67% in those without comorbidity. 87

Financial considerations also may intrude: for example, reluctance to diagnose depression in a patient with little or no mental health third-party coverage because the patient may be unable to obtain care once the diagnosis is made. The physician may find it necessary to treat specific physical symptoms (e.g., insomnia, pain, fatigue) because these nonpsychiatric disorders will be covered. Rost and colleagues describe some of the reasons that physicians deliberately miscode diagnoses. 80

Treatment Barriers

Some patients may be unwilling to accept a diagnosis of depression and thus will not accept any treatment. Others may be hesitant about beginning specific treatments. Some patients are reluctant to take antidepressants for fear of “becoming addicted,”“needing a crutch,” taking “mind-control drugs,” or for other reasons; some may then be prone to mislabel pretreatment symptoms as drug-related after beginning on antidepressants. 88 Other patients will avoid psychotherapy, fearing it to be too intrusive, complicated, lengthy, expensive, or overly focused on childhood experiences. Patients who begin treatment may be dissuaded by unexpected or unpleasant side effects of medications, delay in sufficient improvement, or difficulty in forming an alliance with a psychotherapist. Patients also may be reluctant to see a mental health specialist even if such services are available.

Even if patients initially agree to treatment, they must adhere to enough of a treatment plan to make it likely that outcomes will be improved. Many patients discontinue their medications within the first month. 89 Patient education improves adherence for those with depression in almost all studies in which it has been examined, as it does for many other medical conditions. The difference between outcomes of adherent and nonadherent patients may be considerable, equivalent to the difference between active antidepressant use and a placebo. 90

Several physician-related barriers exist as well. As noted above, too many physicians interpret a depression as “appropriate” for the patient's circumstances and thus not in need of treatment. At other times, physicians will fail to appreciate the duration or severity of a depression and take an inappropriately expectant approach, withholding treatment for a certain time or unless certain conditions are met.

Even when the physician decides that treatment is warranted, the treatment offered may be suboptimal. Antidepressants may be prescribed in inadequate doses or for periods too short to be effective. A common problem is that a physician reacts to reports of side effects that occur shortly after starting an antidepressant by discontinuing the drug, lowering the dose below the therapeutic range, or switching to another drug. This may lead to a series of inadequate drug trials, resulting in multiple side effects but no improvement. Not uncommonly, the patient may decide to forgo further treatment.

Similar problems may occur with psychotherapy. Because few physicians are trained in the empirically proven effective psychotherapies, brief office counseling may be offered. This results in psychotherapy of inadequate intensity or duration. Even if referral is made to a mental health practitioner, that clinician too may undertake a form of psychotherapy (most commonly psychodynamic psychotherapy) that has not been proved to be efficacious for depression.

A number of health care system factors also serve as barriers to treatments. Third-party coverage for mental health care may be limited or nonexistent. Thus, patients may be covered for only a certain number, duration, or frequency of psychotherapy sessions. Even though the empirically validated psychotherapies generally require only 12 to 20 sessions, this often exceeds a health care plan's limits for psychotherapy. Visits for medication checks, even if provided by the primary care physician, may be considered part of the mental health benefit, so the lowered limits on visits, percentage of reimbursement, or total costs covered and any higher copayments may apply. In some settings in which mental health care is carved out, primary care physicians may not be reimbursed for any treatment of depression they provide.

In many areas (particularly rural), availability of mental health professionals may be limited, and patients must make do with whatever care the primary care physician or a limited mental health clinician community can provide. Patients who are covered by mental health carve outs must accept the care provided through that system, even if it is difficult to access or limited in provision.

It is likely that the use of newer antidepressants, despite being more expensive than older agents, results in equal or lower total costs overall by reducing adverse drug reactions, drug monitoring, and hospitalizations for worsened depression or other adverse events (e.g., severe side effects, suicide attempts). 91 , 92 Nonetheless, some managed care organizations continue to influence treatment by formulary restrictions of antidepressant drugs, often in favor of older, less expensive, and less safe choices. Managed care organizations also may influence physician behavior by discouraging appropriate specialty referrals, thus reducing access of depressed patients in need of specific psychotherapies or more expert psychopharmacologic care.

Barriers to recognition, diagnosis, and optimal treatment are summarized in Table 3 .

Some Barriers to Recognition, Diagnosis, and Optimal Treatment of Depression *

ACTIVITIES TO REDUCE BARRIERS

Many professional organizations and advocacy groups have drawn attention to the undertreatment of depression and the need to increase public and professional awareness. For example, a consensus panel sponsored by the National Depression and Manic-Depressive Association issued a report on undertreatment of depression, 93 proposing five immediate steps to reduce the gap between knowledge about depression and actual treatment received: enhancing the role of patients and families, developing performance standards for behavioral health care, increasing provider knowledge and awareness, enhancing collaboration among providers for disease management, and conducting research for new treatments.

Many attempts have been made to identify critical skills and knowledge for primary care physicians. A model curriculum for physicians to diagnose and treat the most common mental and behavioral disorders seen in primary care settings has been developed by a task force of the Society for General Internal Medicine, with input from the American College of Physicians, the American Academy of Physician and Patient, the American Association of Medicine and Psychiatry, and the American Psychiatric Association. 94 Major depression and dysthymia are included among the “mental disorders of central importance in primary care.”

The importance of family physicians has been highlighted by publications such as a White paper of the American Academy of Family Physicians that referred to mental health services as “an essential component of comprehensive primary medical care.” 95 A model curriculum for the psychiatric training of family practitioners also has been developed. 96

The primary care version of DSM-IV is designed to assist in the recognition and diagnosis of depression; practice guidelines for treating major depression in adults in primary care settings have been developed by the AHCPR. The American Psychiatric Association, with input from many medical organizations, also has developed treatment guidelines for major depression in adults, which are primarily directed at psychiatrists, but may be helpful to primary care physicians as well. 97

An example of an approach to teaching the interviewing skills needed to increase recognition of depression is McWhinney's “patient-centered” and “problem-based” approach to interviewing, which has been extensively tested in Great Britain. 98 These techniques may be taught to trainees or self-taught by practicing physicians. Evidence suggests that depression-recognition skills are improved and that the patients of physicians using these techniques have better clinical outcomes. 99

Once the diagnosis is made and treatment initiated, so-called disease management programs may assist with clinical monitoring and patient adherence. Several pharmaceutical manufacturers and managed care entities have developed proprietary programs to help educate patients about depression, assist physicians in tracking the course of a patient's illness, and increase treatment adherence. The effectiveness of such programs is not currently known. Model programs such as those of Schulberg et al., 74 Katon et al., 77 and others, which have been or are being rigorously studied, provide additional, on-site staff for treatment as well as physician education and guideline utilization.

For the past 10 years, the National Institute of Mental Health has operated the Depression Awareness, Recognition, and Treatment program, 100 which includes educational components directed to the public, professionals, and employers. More recently, it has emphasized the importance of recognizing and treating depression when it co-occurs with other general medical disorders. A similar, nongovernmental approach was the Defeat Depression Campaign, a public and professional education campaign undertaken jointly by the Royal College of Psychiatrists and the Royal College of General Practitioners that ran in the United Kingdom from 1992 through l996. The effects of the campaign are currently being evaluated. 101

Other campaigns that emphasize public awareness include National Depression Screening Day (part of National Mental Illness Awareness Week) each October and the National Public Education Campaign on Clinical Depression, a public service campaign launched in 1993. The latter is sponsored by the National Mental Health Association and cosponsored by more than 100 professional groups and advocacy groups. The National Association for Research on Schizophrenia and Affective Disorders (NARSAD) also has a public education campaign on depression, whose slogan is “depression is a flaw in chemistry, not character.”

The American Medical Association has adopted policies that emphasize physician and public education, the need for outcomes research, and the importance of equivalent third-party coverage for psychiatric disorders. The following statements, recommended by the Council on Scientific Affairs, were adopted as AMA Policy at the AMA Interim Meeting in December 1997: (1) The AMA encourages medical schools, primary care residencies, and other training programs as appropriate to include the appropriate knowledge and skills to enable graduates to recognize, diagnose, and treat depression, both when it occurs by itself and when it occurs with another general medical condition. (2) The AMA also encourages all physicians providing clinical care to acquire the same knowledge and skills. (3) The AMA encourages additional research into the course and outcomes of patients with depression who are seen in general medical settings and into the development of clinical and systems approaches designed to improve patient outcomes. Furthermore, any approaches designed to manage care by reduction in the demand for services should be based on scientifically sound outcomes research findings. (4) The AMA fully supports equivalent third-party coverage for all psychiatric disorders, including depression, with that for other medical disorders, and it strongly opposes any arbitrary restrictions or limitations on the provision of mental health services. (5) The AMA will work with the National Institute on Mental Health and appropriate medical specialty and mental health advocacy groups to increase public awareness about depression, to reduce the stigma associated with depression, and to increase patient access to quality care for depression.

Depression, a commonly occurring disorder in the general population, is seen even more frequently in general medical settings and is associated with marked individual and family suffering, an elevated risk of suicide, functional impairment, and a high economic toll in health care costs and lost productivity. Diagnostic criteria are well established, and a number of screening tools exist for use in symptomatic patients. Highly effective psychopharmacologic and psychotherapeutic treatments are available. Most cases of depression seen in general medical settings are milder forms of the illness than are typically seen in specialty settings, and they are frequently amenable to treatment in the primary care setting by those with appropriate expertise.

Depression frequently co-occurs with a number of chronic general medical illnesses, and such comorbidity may complicate the recognition of a depressive illness. Co-occurring depression often impairs patient adherence to medical care and may seriously worsen the course and prognosis of both conditions. Therefore, it is essential to diagnose and treat such co-occurring depression.

Only about half of all cases of depression are recognized and diagnosed in primary care settings, although such unrecognized cases generally are milder and more self-limited in nature. Improved recognition by physicians is largely associated with attitudes about depression and the use of certain specific interviewing skills. Even when cases are recognized, both pharmacologic and psychotherapeutic treatments provided often fall short of existing practice guidelines. When practice guidelines are followed, patient outcomes are quite good.

Barriers to diagnosing and treating depression in general medical settings include those related to stigma; patient somatization and denial; time; patient adherence to treatment; physician knowledge and skill deficits; lack of availability of providers and specific treatments; limitations of third-party coverage; and restrictions on specialist, drug, and psychotherapeutic care. A number of programs are under way to reduce these barriers, but undertreatment remains a serious problem.

Acknowledgments

Members and staff of the Council on Scientific Affairs at the time this report was prepared: Ronald M. Davis, MD, Detroit, Mich (Chair); Joseph A. Riggs, MD, Haddon Fields, NJ (Chair-Elect); Roy D. Altman, MD, Miami, Fla; Hunter C. Champion, New Orleans, La; Scott D. Deitchman, MD, MPH, Decatur, Ga; Myron Genel, MD, New Haven, Conn; John P. Howe III, MD, San Antonio, Tex; Mitchell S. Karlan, MD, Los Angeles, Calif; Mohamed Khaleem Khan, MD, PhD, Boston, Mass; Nancy H. Nielsen, MD, PhD, Buffalo, NY; Michael A. Williams, MD, Baltimore, Md; Donald C. Young, MD, Iowa City, Iowa; Linda B. Bresolin, PhD (CSA Secretary), Barry D. Dickinson, PhD (CSA Assistant Secretary), Chicago, Ill; Larry S. Goldman, MD (Department of Psychiatry, University of Chicago).

Essay On Depression: Causes, Symptoms And Effects

Our life is full of emotional ups and downs, but when the time of down lasts too long or influences our ability to function, in this case, probably, you suffer from common serious illness, which is called depression. Clinical depression affects your mood, thinking process, your body and behaviour. According to the researches, in the United States about 19 million people, i.e. one in ten adults, annually suffer from depression, and about 2/3 of them do not get necessary help. An appropriate treatment can alleviate symptoms of depression in more than 80% of such cases. However, since depression is usually not recognized, it continues to cause unnecessary suffering.

Depression is a disease that dominates you and weakens your body, it influences men as well as women, but women experience depression about two times more often than men.

Since this issue is very urgent nowadays, we decided to write this cause and effect essay on depression to attract the public attention one more time to this problem. I hope it will be informative and instructive for you. If you are interested in reading essays on similar or any other topic, you should visit our website . There you will find not only various essays, but also you can get help in essay writing . All you need is to contact our team, and everything else we will do for you.

Depression is a strong psychological disorder, from which usually suffers not only a patients, but also his / hers family, relatives, friends etc.

General information

More often depression develops on the basis of stress or prolonged traumatic situation. Frequently depressive disorders hide under the guise of a bad mood or temper features. In order to prevent severe consequences it is important to figure out how and why depression begins.

Symptoms and causes of depression

As a rule, depression develops slowly and insensibly for a person and for his close ones. At the initial stage most of people are not aware about their illness, because they think that many symptoms are just the features of their personality. Experiencing inner discomfort, which can be difficult to express in words, people do not ask for professional help, as a rule. They usually go to doctor at the moment, when the disease is already firmly holds the patient causing unbearable suffering.

Risk factors for depression:

• being female;
• the presence of depression in family anamnesis;
• early depression in anamnesis;
• early loss of parents;
• the experience of violence in anamnesis;
• personal features;
• stressors (parting, guilt);
• alcohol / drug addiction;
• neurological diseases (Parkinson's disease, apoplexy).

Signs of depression

Depression influences negatively all the aspects of human life. Inadequate psychological defense mechanisms, in their turn, affect destructively not only psychological, but also biological processes.

The first signs of depression are apathy, not depending on the circumstances, indifference to everything what is going on, weakening of motor activity; these are the main clinical symptoms of depression . If their combination is observed for more than two weeks, urgent professional help is required.

Psychological symptoms:

• depressed mood, unhappiness;
• loss of interest, reduced motivation, loss of energy;
• self-doubt, guilt, inner emptiness;
• decrease in speed of thinking, inability to make decisions;
• anxiety, fear and pessimism about the future;
• daily fluctuations;
• possible delirium;
• suicidal thoughts.

Somatic symptoms:

• vital disorders;
• disturbed sleep (early waking, oversleeping);
• eating disorders;
• constipation;
• feeling of tightness of the skull, dizziness, feeling of compression;
• vegetative symptoms.

Causes of depression

It is accepted to think in modern psychiatry that the development of depression, as well as most of other mental disorders, requires the combined effect of three factors: psychological, biological and social.

Psychological factor (“Personality structure”)

There are three types of personality especially prone to depression:

1) “Statothymic personality” that is characterized by exaggerated conscientiousness, diligence, accuracy;

2) Melancholic personality type with its desire for order, constancy, pedantry, exessive demands on itself;

3) Hyperthymic type of personality that is characterized by self-doubt, frequent worries, with obviously low self-esteem.

People, whose organism biologically tends to depression development, due to education and other social environmental factors form such personality features, which in adverse social situations, especially while chronic stress, cause failure of psychological adaptation mechanisms, skills to deal with stress or lack of coping strategies.

Such people are characterized by:

• lack of confidence in their own abilities;
• excessive secrecy and isolation;
• excessive self-critical attitude towards yourself;
• waiting for the support of the close ones;
• developed pessimism;
• inability to resist stress situations;
• emotional expressiveness.

Biological factor:

• the presence of unfavorable heredity;
• somatic and neurological head injury that violated brain activity;
• changes in the hormonal system;
• chronobiological factors: seasonal depressive disorders, daily fluctuations, shortening of REM sleep;
• side effects of some medications.
• Heredity and family tendency to depression play significant role in predisposition to this disease. It is noticed that relatives of those who suffer from depression usually have different psychosomatic disorders.

Social factor:

• the presence of frequent stress situations, chronic stress;
• adverse family relationships;
• adverse childhood experience, the absence of tenderness from parents, ill-treatment and sexual harassment, interpersonal loss, severe methods of education, negative childhood memories;
• urbanization;
• significant changes in the life;
• population migration;
• increased lifetime.

People in a state of chronic stress suffer from depression more often. If some acute stress situation happens during the period of chronic stress, the probability of depression symptoms development increases.

If you decide to fight the depression, remember that you are not alone! Every fifth person in the world at least once in the life experienced depression. If you notice the signs of depression that disturb you for more than two weeks, you should go to the specialist.

Do not delay visit, in this case time does not heal. The professionalism of the doctors and a complex program of treatment will help to get rid of any kind of depression.

Where to go for help

If you do not where to go for help, ask your family physician, obstetrician, gynecologist or the clinic. In an emergency situation, the emergency doctor can provide temporary help for patients with emotional problems and give them an advice where and how they can ask for the further help.

Here is the list of people and organizations that can diagnose and suggest a course of treatment, or can give a direction to the examination and treatment.

• Family doctors.
• Such specialists as psychiatrists, psychologists, social workers and consultants on mental health.
• Health maintenance organizations.
• Local centers for the treatment of mental illness.
• The Department of Psychiatry in hospitals and outpatient clinics.
• Programs at universities and medical schools.
• Family assistance services and social services departments.
• Private clinics and institutions.
• Care centers in the workplace.
• Local health and (or) mental health communities.

It is very important in depressive episode treatment to understand that this is depression of a certain person, do not make attempts to excessive generalization of symptoms and factors of disease development. It requires personal approach to each patient.

So, as you can see, depression is a serious disease that requires professional treatment. If you manage to recognize the signs of depression at its early stage and ask for professional help, you can successfully overcome this problem. I hope this essay about depression was useful for you, and you got what you were looking for.

Calculate Your Price

• Free Samples
• Popular topics

Recent posts

• Best Dissertation Writer: Stop Being Helpless
• Essay On Empathy: How Not to Lose Yourself
• Competent and Experienced Online Assignment Writing Service
• Papers Editing Services Help to Find Your Calling
• It Is Time to Order Best Dissertation Writing Services

Tired of endless home tasks on quarantine? No more worries!

Use your limited chance to get a special 22% OFF!

Apply the code "stayhome" while placing your order and enjoy the outstanding results!

Clinical Depression: Causes and Development Essay

• To find inspiration for your paper and overcome writer’s block
• As a source of information (ensure proper referencing)
• As a template for you assignment

Depression involves conditions that are associated with mood elevation or lowering. The disorder is common among individuals who have undergone a stressful event. Low self-esteem and overly self-critical can lead to depression. Aaron Beck is one of the psychologists who propounded that individuals who are susceptible to depression may develop unhealthy core beliefs about themselves and others. The beliefs dominate the patients’ lives and are activated by happenings that carry specific importance to them. Therefore, according to Aaron Beck, the causes and development of depression can be explained through the concepts of schema and negative cognitive triad.

Human beings use a specific framework to organize and interpret the vast information available in their environment. According to Aaron Beck schema is a cognitive framework that individuals utilize to interpret information from their social environment (Şimşek et al., 2021). For instance, traumatic events may trigger an individual to develop a set of negative beliefs about themselves. Therefore, Aaron Beck believed that depressed people are prone to negative self-schema (Şimşek et al., 2021). An example of a negative self-schema is abandonment which makes people constantly afraid of relationships. Negative self-schema leads to depression since it makes people pessimistic about themselves.

Additionally, Aaron Beck and other theorists used the concept of the negative cognitive triad to explain the development of depressive conditions. The theorists opined that people with depressive symptoms have negative and hopeless thoughts about themselves and their environments (Beck et al., 2021). The negative cognitive triad is a three-dimensional concept that involves uncontrollable negative thoughts that are automatic and spontaneous, focusing on the self, world, and future (Beck et al., 2021). An example of a negative cognitive triad that involves self is “I am an ugly student.” Meanwhile, a negative cognitive triad reflects on the world can be statements such as “Everyone hates me.” For the future, a negative cognitive triad may include a statement such as “I am useless since things will never change.” Therefore, schemas and negative cognitive triads play a significant role in clinical depression development.

Beck, A. T., Finkel, M. R., & Beck, J. S. (2020). The Theory of Modes: Applications to Schizophrenia and Other Psychological Conditions. Cognitive Therapy and Research, 45 , pp. 391-400.

Şimşek, O. M., Koçak, O., & Younis, M. Z. (2021). The impact of interpersonal cognitive distortions on satisfaction with life and the mediating role of loneliness. Sustainability , 13 (16), pp. 9293.

• Generalized Anxiety Disorder Diagnostics
• Financial Difficulties in Childhood and Adult Depression in Europe
• Learning Tips for Incoming Students
• "Money as a Weapon" System and Fiscal Triad
• Processes, Learning and Schema Theory
• Factors That Impact Mental Health
• Posttraumatic Stress Disorder: Case Presentation Report
• Causes of Premature Termination of Psychological Treatment
• Major Depressive Disorder: Prevalence and Incidence
• Bipolar Disorder: A Major Psychological Issue in America
• Chicago (A-D)
• Chicago (N-B)

IvyPanda. (2023, August 26). Clinical Depression: Causes and Development. https://ivypanda.com/essays/clinical-depression-causes-and-development/

"Clinical Depression: Causes and Development." IvyPanda , 26 Aug. 2023, ivypanda.com/essays/clinical-depression-causes-and-development/.

IvyPanda . (2023) 'Clinical Depression: Causes and Development'. 26 August.

IvyPanda . 2023. "Clinical Depression: Causes and Development." August 26, 2023. https://ivypanda.com/essays/clinical-depression-causes-and-development/.

1. IvyPanda . "Clinical Depression: Causes and Development." August 26, 2023. https://ivypanda.com/essays/clinical-depression-causes-and-development/.

Bibliography

IvyPanda . "Clinical Depression: Causes and Development." August 26, 2023. https://ivypanda.com/essays/clinical-depression-causes-and-development/.

Clinical Depression Essay

Despite the stigma, sufferers of such disorders can function no matter what the symptoms might be. Having a disorder does not make you are any less of a human being. Humans are unique creatures with different ways of handling information, emotions, and inner thoughts. Although it may seem confusing, being different is normal in terms of the human race . Depression is a serious condition where one may encounter episodes of sadness, which sometimes occur without reason.

In fact, it is becoming more and more common for teens to experience depressive episodes. From observations of the past, “A person born in the 1930s was likely to have his or her first depressive episode between the ages of thirty and thirty-five” (Bloch, Douglas). Historically, depression was less common to experience at such a young age. Today, individuals are more likely to experience these episodes of depression earlier in life . Stating an observation of later years, Bloch says, “If you were born in 1956, your initial episode occurred between twenty and twenty-five” (Bloch).

Related posts:

• Social Sciences
• Natural Sciences
• Formal Sciences
• Professions
• Extracurricular

“15% of people with major depressive disorder die by suicide” (Major). Major depressive disorder or the common term depression is a medical illness that involves the mind and body. Major depressive disorder and clinical depression, it affects how you feel, think and behave. Depression can lead to a variety of emotional and physical problems. mental disorder Depression is usually characterized by low mood, accompanied with low self-esteem and by the loss of interest or pleasure in normal activities.

First, to be diagnosed with depression the person has to have five or more symptoms of depression for at least two weeks. Some symptoms include feeling sad, hopeless, worthless, fatigue or lack of interest, thoughts of suicide, withdrawal from usual activities or even pessimistic. Also, if the person has been experience signs of insomnia, in which the person has sleep problems.

Also, the exact cause of depression is unknown but researchers believe it is caused by a chemical imbalance in the brain, which may be heredity or caused by events a person’s life. Some types of depression seem to run in the family, but depression can occur for people who do not have a family. Also, stressful life changes or events can cause depression. Men and women of all races, ages and economic levels can have depression.

Furthermore, Depression is a chronic illness that usually requires long-term treatment, like diabetes or high blood pressure. Most people with depression feel better with medication, psychological counseling or other treatment. Depression can be treated in variety of ways but usually with the help of medications and counseling. Studies show that it is better for a person suffering from depression to combine antidepressant drug therapy with psychotherapy. Another treatment is called Electroconvulsive is a treatment that causes seizures by means of an electric current. Electroconvulsive may improve the mood of severely depressed or suicidal people who do not respond to other treatments. Also, research is now being conducted on transcranial magnetic stimulation (TMS), which alters brain function in a way similar to ECT, but with fewer side effects. Use of light therapy for depressive symptoms in the winter months and interventions to restore a normal sleep cycle may be effective for relieving depression. It is important for the depressed person to live a healthy lifestyle while undergoing treatment. This includes avoiding drugs and alcohol, which makes depression worse. Also, eat well-balance meals, get regular exercise and sleep and even seek supportive relationships.

In conclusion, depression can affect anyone at any age. If a person with depression does not seek medical help then the mental disorder might become worse and make the person commit suicide.

• Undergraduate
• High School
• Architecture
• American History
• Asian History
• Antique Literature
• American Literature
• Asian Literature
• Classic English Literature
• World Literature
• Creative Writing
• Linguistics
• Criminal Justice
• Legal Issues
• Anthropology
• Archaeology
• Political Science
• World Affairs
• African-American Studies
• East European Studies
• Latin-American Studies
• Native-American Studies
• West European Studies
• Family and Consumer Science
• Social Issues
• Women and Gender Studies
• Social Work
• Natural Sciences
• Pharmacology
• Earth science
• Agriculture
• Agricultural Studies
• Computer Science
• IT Management
• Mathematics
• Investments
• Engineering and Technology
• Engineering
• Aeronautics
• Medicine and Health
• Alternative Medicine
• Communications and Media
• Advertising
• Communication Strategies
• Public Relations
• Educational Theories
• Teacher's Career
• Chicago/Turabian
• Company Analysis
• Education Theories
• Shakespeare
• Canadian Studies
• Food Safety
• Relation of Global Warming and Extreme Weather Condition
• Movie Review
• Admission Essay
• Annotated Bibliography
• Application Essay
• Article Critique
• Article Review
• Article Writing
• Book Review
• Business Plan
• Business Proposal
• Capstone Project
• Cover Letter
• Creative Essay
• Dissertation
• Dissertation - Abstract
• Dissertation - Conclusion
• Dissertation - Discussion
• Dissertation - Hypothesis
• Dissertation - Introduction
• Dissertation - Literature
• Dissertation - Methodology
• Dissertation - Results
• GCSE Coursework
• Grant Proposal
• Marketing Plan
• Multiple Choice Quiz
• Personal Statement
• Power Point Presentation
• Power Point Presentation With Speaker Notes
• Questionnaire
• Reaction Paper

Research Paper

• Research Proposal
• SWOT analysis
• Thesis Paper
• Online Quiz
• Literature Review
• Movie Analysis
• Statistics problem
• Math Problem
• All papers examples
• How It Works
• Money Back Policy
• Terms of Use
• Privacy Policy
• We Are Hiring

Depression as a Clinical Disorder, Research Paper Example

Pages: 4

Words: 1192

Hire a Writer for Custom Research Paper

Use 10% Off Discount: "custom10" in 1 Click 👇

You are free to use it as an inspiration or a source for your own work.

Definition and Symptoms

In simple medical terms, depression can be defined as a mood disturbance characterized by feelings of sadness, despair, and discouragement that results from some kind of personal loss or tragedy. In contrast, the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) defines clinical depression as an abnormal emotional state  characterized by exaggerated feelings of melancholy, dejection, and worthlessness. In its most severe form, clinical depression causes serious physiologic alterations related to body functions and the human brain. Psychologically, clinical depression can be expressed “in a wide spectrum of affective, physiologic, cognitive, and behavioral manifestations” that are often accompanied by delusions and confusion concerning time, place, and identity (DSM-V, 2013, p. 245).

There are basically seven significant symptoms related to clinical depression–1), a depressed mood that endures all day and every day; 2), a marked decrease in personal interests like hobbies and in pleasure for most of the day every single day; 3), significant weight loss due to a lack of interest in eating; 4), insomnia that endures every single day and night; 5), fatigue or a loss of physical energy nearly every single day; 6), a decrease in the ability to think and/or concentrate nearly every single day; and 7), recurring thoughts or talking about suicide nearly every single day. Taken as a whole, these major symptoms “cause clinically significant distress or impairment in social, occupational or other important areas of functioning” on a daily basis, meaning that they tend to severely disrupt a person’s normal everyday activities (DSM-V, 2013, p. 245).

Generally speaking, if a person exhibits five or more of these symptoms for more than two weeks or exhibits “considerable impairment in normal functioning for more than one month” (Clinical Depression, 2015), then the person is considered as suffering from clinical depression. It should also be mentioned that if any of these symptoms are caused by the direct physiological effects of a substance (e.g., a drug, alcohol, or some type of prescribed medication) or a general medical condition like hypothyroidism, then the person is not clinically depressed ((DSM-V, 2013, p. 245).

Common Causes of Clinical Depression

Many of the most current psychological theories concerning clinical depression suggests that the disorder is caused by numerous entities that often overlap into a complex mixture of causes. Overall, clinical depression is caused by the abnormal interaction of certain brain chemicals and hormones that affect an individual’s energy level, emotional feelings, sleeping and eating habits. These chemical interactions “are linked to many complex causes–a person’s family history of illness, biochemical and psychological make-up, prolonged stress, and traumatic life crisis” (Clinical Depression, 2015), such as losing a loved one to a tragic accident, losing a long-held job, or experiencing a bitter divorce after years of marriage.

Often, the causes of clinical depression in some individuals cannot be ideally identified, meaning that psychologists and other medical specialists are unable to identify exactly what is causing a person to suffer from depression. However, it is clear that numerous stressors are responsible, all of which come about through changes related to important brain chemicals like  serotonin, a naturally occurring chemical found in blood platelets and specific cells in the human brain, and the naturally occurring brain hormone norepinephrine (Clinical Depression, 2015).

Depression and Human Behavior

From a clinical standpoint, it appears that the links between depression and human behavior are directly related to the major symptoms of the disorder. For example, an individual suffering from clinical depression generally loses all interest in sex and activities that were once enjoyable or stimulating. The individual also loses interest in eating his/her favorite types of food which can affect body weight and physical stamina. Also, the individual changes his/her sleeping patterns by either staying up all night or sleeping all day. Lastly, the individual becomes unable to remember simple things like what time he/she has to be at work or where someone lives. All of these behavioral changes and many more are due to clinical depression. In addition, some other related behavioral changes includes physical aggression, a complete withdrawal from all normal activities, anger, apathy or indifference to one’s life, and even thoughts about suicide as the only way out.

Case Examples

Two excellent case study examples are as follows. First, M., a 50 year old white female, tells her doctor that she feels nervous and upset most of the time and that she has lost interest in eating and in her hobbies that include sewing and painting. M. also mentions that she is having a hard time falling asleep and that she stays up all night and ends up crying herself to sleep. These symptoms have also prevented M. from functioning as she is expected at her place of employment. M. also mentions that she has thought about suicide. Therefore, after filling out a questionnaire, M.’s psychologist determines that she is suffering from clinical depression, due to the fact that she has been experiencing these and other symptoms for more than a year.

In contrast, Mr. P., a 45 year old white male, arrives at his doctor’s office complaining of dizziness and disorientation. Since Mr. P. has a history of diabetes, his doctor’s  initial diagnosis is that he is suffering from some type of withdrawal related to not taking his insulin shots. But later on during a conversation with a psychologist, Mr. P. admits that he has not slept for a week and has lost all interest in his job, his family, and in extracurricular activities outside of his home. Mr. P also admits that he has a hard time concentrating his thoughts and does not have the patience to even read a newspaper or watch TV. After this conversation, the psychologist determines that Mr. P is suffering from clinical depression and that he must begin intensive counseling and a regimen of medications.

Treatment Options

Today in 2015, there are numerous types of medications for the treatment of clinical depression and its cousin manic depression, often referred to as bipolar disorder.  Most of these medications are known as antidepressants which block the reuptake of amine neurotransmitters in the brain; these are also known as MAO inhibitors. Due to the fact that clinical depression appears to be on the rise as a major psychological disturbance, a variety of new antidepressant medications “have been developed which lack the side affects of earlier medications,” such as dizziness, disorientation, and appetite suppressant. These new drugs are referred to as SSRI’s or Serotonin-Specific Reuptake Inhibitors like Prozac, Zoloft and Paxil which “selectively block the reuptake of the major neurotransmitter, serotonin” (Clinical Depression, 2015).

Besides medication, there is also psychotherapy as a treatment option for some sufferers of clinical depression. Generally, psychotherapy is part of a much broader category of treatment options known as Interpersonal and Cognitive Behavior therapies that focus upon a person’s personal relationships and his/her viewpoints on individuals that matter the most to them. Overall, this type of therapy “helps the individual to change the negative style of thinking and behaving” while also exposing “internal psychological conflicts that are typically thought to be rooted in childhood” (Clinical Depression, 2015).

Clinical depression. (2015). University of Pittsburgh School of Medicine. Retrieved from http://www.medschool.pitt.edu/somsa/Depression.HTML

The diagnostic and statistical manual of mental disorders, DSM-V. (2013). Washington, DC: American Psychiatric Association.

Stuck with your Research Paper?

Get in touch with one of our experts for instant help!

A Growing Hole in the Safety Net, Case Study Example

Conflict Between Russia and Ukraine From 2013-2015, Essay Example

Time is precious

don’t waste it!

Plagiarism-free guarantee

Privacy guarantee

Secure checkout

Money back guarantee

Related Research Paper Samples & Examples

The risk of teenagers smoking, research paper example.

Pages: 11

Words: 3102

Impacts on Patients and Healthcare Workers in Canada, Research Paper Example

Pages: 7

Words: 1839

Death by Neurological Criteria, Research Paper Example

Words: 2028

Ethical Considerations in End-Of-Life Care, Research Paper Example

Pages: 5

Words: 1391

Ethical Dilemmas in Brain Death, Research Paper Example

Words: 2005

Politics of Difference and the Case of School Uniforms, Research Paper Example

Pages: 2

Words: 631